Item 5.07. Submission of Matters to a Vote of Security Holders.






At the 2021 Annual Meeting of Shareholders of Regeneron Pharmaceuticals, Inc.
("Regeneron" or the "Company") held on June 11, 2021, Regeneron's shareholders
voted on the matters set forth below.

Proposal 1 - Election of Directors


The following nominees for Class III directors were elected to serve until the
2024 Annual Meeting of Shareholders and until their successors are duly elected
and qualified based upon the following votes:



Nominee                                     For            Against         Abstain        Broker Non-Votes
N. Anthony Coles, M.D.                    75,381,886       32,535,136      

  78,137              5,619,610
Arthur F. Ryan                            86,030,481       21,860,350        104,328              5,619,610
George L. Sing                            54,880,615       53,055,342         59,202              5,619,610

Marc Tessier-Lavigne, Ph.D.               72,073,887       35,848,999      

  72,273              5,619,610

Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm

The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021 was approved based upon the following votes:





For:       109,498,984
Against:     4,057,028
Abstain:        58,757

© Edgar Online, source Glimpses